Literature DB >> 11845138

I-123 MIBG scintigraphy in idiopathic dilated cardiomyopathy: where next?

Kevin C Allman, Avijit Lahiri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845138     DOI: 10.1067/mnc.2002.121175

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  25 in total

1.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.

Authors:  J Yamazaki; H Muto; T Kabano; S Yamashina; S Nanjo; A Inoue
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

2.  Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.

Authors:  C Zhao; N Shuke; W Yamamoto; A Okizaki; J Sato; Y Ishikawa; T Ohta; N Hasebe; K Kikuchi; T Aburano
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

3.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

Authors:  P Merlet; C Benvenuti; D Moyse; F Pouillart; J L Dubois-Randé; A M Duval; D Loisance; A Castaigne; A Syrota
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

4.  Effects of cardiac sympathetic innervation on coronary blood flow.

Authors:  M F Di Carli; M C Tobes; T Mangner; A B Levine; O Muzik; P Chakroborty; T B Levine
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

5.  Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities.

Authors:  F I Parthenakis; V K Prassopoulos; S I Koukouraki; E A Zacharis; G F Diakakis; N K Karkavitsas; P E Vardas
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

6.  Changes in myocardial oxygen consumption and efficiency with heart failure therapy measured by 11C acetate PET.

Authors:  R S Beanlands; M Schwaiger
Journal:  Can J Cardiol       Date:  1995-04       Impact factor: 5.223

7.  Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Authors:  G A Somsen; B van Vlies; P A de Milliano; J J Borm; E A van Royen; E Endert; K I Lie
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

8.  Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy.

Authors:  K Murata; S Kusachi; T Murakami; K Nogami; M Murakami; S Hirohata; Y Tominaga; I Komatsubara; T Tsuji
Journal:  Clin Cardiol       Date:  1997-01       Impact factor: 2.882

9.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

10.  Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart.

Authors:  H Calkins; K Allman; S Bolling; M Kirsch; D Wieland; F Morady; M Schwaiger
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.